Skip to main content
CHCT logo

CHCT · Community Healthcare Trust Inc

Track CHCT — free
$14.84 -0.03 (-0.20%) At close · Aug 21
Market Cap
$426.08M
Shares
28.65M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$14.87 Open$14.65 Day$14.59–14.94 52W close$13.31–19.02 Avg vol 30d315K Short int1.0M · 3.5% float · 4.7d Short vol67% Last earningsAug 4, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 4

Up next

Next earnings call
Nov 3, 2026 Est · unconfirmed · in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 4, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol Moderate
      Market backdrop VIX 16 · calm Equity put/call 0.58
      Technical
      price trend
      Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −11%
      below
      Price vs 50-day avg −15%
      below
      RSI (14) 28
      oversold
      MACD trend Negative
      52-week position 27%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Weak
      1-month return −19%
      trailing
      6-month return −13%
      trailing
      YTD return −9%
      this year
      Relative strength −24%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $17 › 200d $17 — 50d above 200d
      Institutional flow Accumulating
      +5% holders QoQ · +22 funds added
      Insider flow Accumulating
      Net +$273.0K over 90 days · 0% sells
      Short interest Rising
      3.51% of float · ▲ +4.5% MoM · 4.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      171 holders — mid 3-yr range
      Squeeze score 51
      elevated · 0–100
      Fundamentals
      Fair
      Revenue growth +5%
      Y/Y
      EPS growth +135%
      Y/Y
      Valuation P/E 21.9
      in line
      Balance sheet $528.9M
      net debt
      Quant / Vol
      risk profile
      Moderate
      Volatility 28%
      annualized · 1-yr
      Max drawdown −23%
      past year
      ATR 3.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 4, 2026
      Leased Occupancy · Target Occupancy 92%
      Annualized NOI · Target Occupancy $107M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Sell
      3 · 4 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −11% Bearish
      Price vs 50-day avg
      −15% Bearish
      RSI (14)
      28 Neutral
      MACD trend
      Negative Bearish
      52-week position
      27% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $17 › 200d $17 — 50d above 200d
      Institutional flow Accumulating
      +5% holders QoQ · +22 funds added
      Insider flow Accumulating
      Net +$273.0K over 90 days · 0% sells
      Short interest Rising
      3.51% of float · ▲ +4.5% MoM · 4.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      171 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $13 Now $15 · 27% Range high $19
      vs 200-day avg -11% vs 50-day avg -15%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted EBITDAre non-GAAP $23.25M 2Q 2026
      GAAP → non-GAAP reconciliation
      GAAP EBITDAre 20.47M
      +2.78M Non-cash stock-based compensation expense
      +0K Accelerated amortization of stock-based compensation
      +0K Credit loss reserve
      = Adjusted EBITDAre 23.25M
      Adjusted EBITDAre Annualized non-GAAP $93M 2Q 2026
      Adjusted funds from operations (AFFO) non-GAAP $15.41M Three Months Ended June 30, 2026
      AFFO Payout non-GAAP 87% Q2 2026
      AFFO, Adjusted for other non-cash items non-GAAP $15.64M 2Q 2026
      GAAP → non-GAAP reconciliation
      GAAP AFFO 15.41M
      +24K Non-real estate depreciation and amortization
      -41K Amortization of above (below) market leases
      +255K Amortization of debt issuance costs
      = AFFO, Adjusted for other non-cash items 15.64M
      Annualized NOI non-GAAP $101.44M 2Q 2026
      EBITDAre non-GAAP $20.47M 2Q 2026
      GAAP → non-GAAP reconciliation
      GAAP Net income (loss) 2.36M
      +7.43M Interest expense
      +10.74M Depreciation and amortization
      -12K Deferred Income tax (benefit) expense
      -46K (Gain) loss, net of impairment, on the sale of real estate assets
      = EBITDAre 20.47M
      FAD non-GAAP $12.99M 2Q 2026
      GAAP → non-GAAP reconciliation
      GAAP AFFO, Adjusted for other non-cash items 15.64M
      -202K Leasing commissions
      -1.11M Tenant improvements
      -1.34M Recurring capex
      = FAD 12.99M
      FFO per Common Share non-GAAP $0.48 2Q 2026
      Fixed charge coverage ratio 3 2Q 2026
      Funds from operations (FFO) non-GAAP $13.22M Three Months Ended June 30, 2026
      GAAP → non-GAAP reconciliation
      GAAP Net Income (Loss) 2.36M
      +10.9M Real estate depreciation and amortization
      +0K Credit loss reserve
      -46K (Gain) loss, net of impairment, on the sale of real estate assets
      = FFO 13.22M
      investments in real estate properties 1.2B As of June 30, 2026
      Leased Occupancy 89.8% 2Q 2026
      Leverage ratio 44.6% 2Q 2026
      Minimum debt service coverage ratio 3.2 2Q 2026
      NOI non-GAAP $25.36M 2Q 2026
      GAAP → non-GAAP reconciliation
      GAAP Net income (loss) 2.36M
      +4.89M General and administrative
      +0K Accelerated amortization of deferred compensation
      +0K Severance and transition-related compensation
      +10.74M Depreciation and amortization
      -46K (Gain) loss, net of impairment, on the sale of real estate assets
      +0K Credit loss reserve
      +7.43M Interest expense
      -12K Deferred Income tax (benefit) expense
      -3K Interest and other income, net
      = NOI 25.36M
      Portfolio Leased 89.8% Q2 2026
      Portfolio Occupancy 89.8% Q2 2026
      states with properties 36 As of June 30, 2026
      Tangible net worth 695.59M 2Q 2026
      Tenants 325 Q2 2026
      total square feet of properties 4.5M As of June 30, 2026
      Weighted Average Lease Term 7.2 Q2 2026
      Weighted Average remaining lease term 7.2 2Q 2026
      Equity market cap $467.5M Q4 2025
      Quarter end stock price (per share) $16.42 Q4 2025
      Weighted average interest rate per annum on Revolving Line of Credit 5.2% Q4 2025
      Weighted average interest rate per annum on Term Loans 4.7% Q4 2025

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      REIT - Healthcare Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      CHCT
      Community Healthcare Trust Inc
      this stock
      $426.08M -9.4% +4.7% 21.9 3.5%
      WELL
      Welltower Inc.
      $167.58B +27.9% +35.6% 118.1 2.5%
      VTR
      Ventas, Inc.
      $47.54B +19.8% +18.5% 171.6 4.6%
      DOC
      Healthpeak Properties, Inc.
      $14.62B +31.8% +4.5% 60.6 3.5%
      OHI
      Omega Healthcare Investors Inc
      $14.12B +5.4% +13.2% 16.6 4.2%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      171
      % held
      81.1%
      Net QoQ
      +113.3K sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      172
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      1.0M
      Days to cover
      4.7d
      Change
      +43.4K sh
      View
      Short Volume
      Short vol %
      67%
      As of
      Aug 21, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      20
      Value
      $367
      As of
      Jul 23, 2026
      View
      Off-Exchange
      Off-exchange %
      42.9%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net buying
      Net (90d)
      +$273.0K
      Buyers / Sellers
      2 / 0
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $121.2M
      Net income (FY)
      $5.1M
      EPS diluted
      $0.08
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 4, 2026
      This year
      9
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 4, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      CHCT -1.7% -18.9% -12.6% -18.8% -9.4%
      SPY -2.0% +3.3% +11.2% +2.1% +11.8%
      vs SPY +0.3% -22.2% -23.8% -20.9% -21.3%

      Capital returns

      Latest dividend
      $0.33 / share · ex Aug 19, 2026
      Cut 31.3%
      Paid (TTM)
      $1.763 / share · 4 payouts
      Dividend yield (TTM, derived)
      11.86%

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1631569 CUSIP 20369C106 13F (30d) 163 filings 154 filers Visit website Investor relations